IgE and IgE Receptors

Allergy and Allergic Diseases, Second Edition

Volumn 1, Issue , 2009, Pages 103-118

  Sutton, Brian J ^a,b   Beavil, Andrew J ^a   Beavil, Rebecca L ^a   Hunt, James ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Counterreceptor for CD23 (CD21); Galectin 3 heterogeneous group of proteins "histamine releasing factors" (HRF); High affinity receptor (Fc RI); IgE and IgE receptors; IgE crucial role in allergy and allergic diseases; IgE network and prospects for therapeutic intervention; IgE receptor and counterreceptor complexes emergence; Low affinity receptor (CD23 or Fc RII); Peptides and peptide based small molecule inhibitors

Indexed keywords

EID: 80052751920     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444300918.ch5     Document Type: Chapter

References (140)

1. Abramson, J. & Pecht, I. (2007) Regulation of the mast cell response to the type 1 Fcε receptor. Immunol Rev 217, 231-54.
2. Andrásfalvy, M., Péterfy, H., Tóth, G. et al. (2005) The β subunit of the type I Fcε receptor is a target for peptides inhibiting IgEmediated secretory response of mast cells. J Immunol 175, 2801-6.
3. Arnold J.N., Radcliffe, C.M., Wormald, M.R. et al. (2004) The glycosylation of human serum IgD and IgE and the accessibility of identified oligomannose structures for interaction with mannanbinding lectin. J Immunol 173, 6831-40.
4. Asai, K., Kitaura, J., Kawakami, Y. et al. (2001) Regulation of mast cell survival by IgE. Immunity 14, 791-800.
5. Aubry, J.-P., Pochon, S., Graber, P., Jansen, K.U. & Bonnefoy, J.-Y. (1992) CD21 is a ligand for CD23 and regulates IgE production. Nature 358, 505-7.
6. Aubry, J.-P., Pochon, S., Gauchat, J.-F. et al. (1994) CD23 interacts with a new functional extracytoplasmic domain involving N-linked oligosaccharides on CD21. J Immunol 152, 5806-13.
7. Aubry, J.-P., Dugas, N., Lecoanet-Henchoz, S. et al. (1997) The 25-kDa soluble CD23 activates type III constitutive nitric oxide-synthase activity via CD11b and CD11c expressed by human monocytes. J Immunol 159, 614-22.
8. Bacon, K., Gauchat, J.-F., Aubry, J.-P. et al. (1993) CD21 expressed on basophilic cells is involved in histamine release triggered by CD23 and anti-CD23 antibodies. Eur J Immunol 23, 2721-4.
9. Baenziger, J., Kornfeld, S. & Kochwa, S. (1974) Structure of the carbohydrate units of IgE immunoglobulin. J Biol Chem 249, 1889-903.
10. Beavil, A.J., Edmeades, R.L., Gould, H.J. & Sutton, B.J. (1992) α-Helical coiled-coil stalks in the low-affinity receptor for IgE (FcεRII/CD23) and related C-type lectins. Proc Natl Acad Sci USA 89, 753-7.
11. Beavil, A.J., Young, R.J., Sutton, B.J. & Perkins, S.J. (1995) Bent domain structure of recombinant human IgE-Fc in solution by Xray and neutron scattering in conjunction with an automated curve fitting procedure. Biochemistry 34, 14449-61.
12. Beavil, R.L., Graber, P., Aubonney, N., Bonnefoy, J.-Y. & Gould, H.J. (1995) CD23/FcεRII and its soluble fragments can form oligomers on the cell surface and in solution. Immunology 84, 202-6.
13. Bennich, H., Ishizaka, K., Johansson, S.G.O. et al. (1968) Immunoglobulin E, a new class of human immunoglobulin. Bull WHO 38, 151-2.
14. Bestago, M., Vangelista,L., Mandiola, P.A. et al. (2001) Membrane immunoglobulins are stabilised by interchain disulphide bonds occurring within the extracellular membrane-proximal domain. Biochemistry 40, 10686-92.
15. Bieber, T. (1994) FcεRI on human Langerhans cells: a receptor in search of new functions. Immunol Today 15, 52-3.
16. Bonnefoy, J.-Y., Pochon, S., Aubry, J.-P. et al. (1993) A new pair of surface molecules involved in human IgE regulation. Immunol Today 14, 1-2.
17. Borland, G., Edkins, A.L., Acharya, M. et al. (2007) αvβ5 Integrin sustains growth of human pre-B cells through an RGD-independent interaction with a basic domain of the CD23 protein. J Biol Chem J Biol Chem 282, 27315-26.
18. Chang, T.W. (2000) The pharmacologocial basis of anti-IgE therapy. Nat Biotech 18, 157-62.
19. Chen, B.H., Ma, C., Caven, T.H. et al. (2002) Necessity of the stalk region for immunoglobulin E interaction with CD23. Immunology 107, 373-81.
20. Chen, H-Y., Sharma, B.B., Yu, L. et al. (2006) Role of galectin-3 in mast cell functions: galectin-3-deficient mast cells exhibit impaired mediator release and defective JNK expression. J Immunol 177, 4991-7.
21. Conrad, D.H., Campbell, K.A., Bartlett, W.C., Squire, C.M. & Dierks, S.E. (1994) Structure and function of the low affinity IgE receptor. Adv Exp Med Biol 347, 17-30.
22. Davis, K.G., Glennie, M., Harding, S. & Burton, D.R. (1990) A model for the solution conformation of rat IgE. Biochem Soc Trans 18, 935-6.
23. Delespesse, G., Sarfati, M., Wu, C.Y., Fournier S. & Letellier, M. (1992) The low-affinity receptor for IgE. Immunol Rev 125, 77-97.
24. Dempsey, P.W., Allison, M.E.D., Akkaraju, S., Goodnow, C.G. & Fearon, D.T. (1996) C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 271, 348-50.
25. Dierks, S.E., Bartlett, W.C., Edmeades, R.L. et al. (1993) The oligomeric nature of the murine FcεRII/CD23. J Immunol 150, 2372-82.
26. Dorrington, K.J. & Bennich, H.H. (1978) Structure-function relationships in human immunoglobulin E. Immunol Rev 41, 3-25.
27. Erdei, A., Füst, G. & Gergely, J. (1991) The role of C3 in the immune response. Immunol Today 12, 332-7.
28. Fearon, D.T. (1998) The complement system and adaptive immunity. Semin Immunol 10, 355-61.
29. Fearon, D.T. & Carroll, M.C. (2000) Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex. Annu Rev Immunol 18, 393-422.
30. Flores-Romo, L., Shields, J., Humbert, Y. et al. (1993) Inhibition of an in vivo antigen-specific IgE response by antibodies to CD23. Science 261, 1038-41.
31. Ford, J.W., Kilmon, M.A., Haas, K.M. et al. (2006) In vivo murine CD23 destablisation enhances CD23 shedding and IgE synthesis. Cell Immunol 243, 107-17.
32. Frémeaux-Bacchi, V., Fischer, E., Lecoanet-Henchoz, S. et al. (1998) Soluble CD21 (sCD21) forms biologically active complexes with CD23: sCD21 is present in normal plasma as a complex with trimeric CD23 and inhibits soluble CD23-induced IgE synthesis by B cells. Int Immunol 10, 1459-66.
33. Frigeri, L.G., Zuberi, R.I. & Liu, F.-T. (1993) εBP, a β-galactosidebinding animal lectin, recognizes IgE receptor (FcεRI) and activates mast cells. Biochemistry 32, 7644-9.
34. Fujiwara, H., Kikutani, H., Suematsu, S. et al. (1994) The absence of IgE antibody-mediated augmentation of immune responses in CD23-deficient mice. Proc Natl Acad Sci USA 91, 6835-9.
35. Garman, S.C., Kinet, J.-P. & Jardetzky, T.S. (1998) Crystal structure of the human high-affinity IgE receptor. Cell 95, 951-61.
36. Garman, S.C., Wurzburg, B.A., Tarchevskaya, S.S., Kinet, J.-P. & Jardetzky, T.S. (2000) Structure of the Fc fragment of human IgE bound to its high-affinity receptor FcεRIα. Nature 406, 259-66.
37. Garman, S.C., Sechi, S., Kinet, J.-P. & Jardetzky, T.S. (2001) The analysis of the human high affinity IgE receptor FcεRIα from multiple crystal forms. J Mol Biol 311, 1049-62.
38. Gilbert, H.E., Asokan, R., Holers, V.M. & Perkins, S.J. (2006) The 15 SCR flexible extracellular domains of human complement receptor type 2 can mediate multiple ligand and antigen interactions. J Mol Biol 362, 1132-47.
39. Gordon, J. (1993) CD23 and CD72: C-type lectins and B-lymphocyte regulation. Adv Mol Cell Immunol 1A, 71-96.
40. Gould, H.J., Sutton, B.J., Edmeades, R.L. & Beavil, A.J. (1991) CD23/FcεRII: C-type lectin membrane protein with a split personality? Monogr Allergy 29, 28-49.
41. Gould, H.J., Beavil, R.L., Reljic, R. et al. (1997) IgE homeostasis: is CD23 the safety switch? In: Vercelli, D., ed. Molecular Mechanisms of IgE Regulation. John Wiley & Sons, Chichester, UK, pp. 37-59.
42. Gould, H.J., Sutton, B.J., Beavil, A.J. et al. (2003) The biology of IgE and the basis of allergic disease. Annu Rev Immunol 21, 579-628.
43. Gounni, A.S., Lamkhioued, B., Ochiai, K. et al. (1994) High-affinity IgE receptor on eosinophils is involved in defence against parasites. Nature 367, 183-6.
44. Gounni, A.S., Wellemans, V., Yang. J. et al. (2005) Human airway smooth muscle cells express the high affinity receptor for IgE (FcεRI): a critical role of FcεRI in human airway smooth muscle cell function. J Immunol 175, 2613-21.
45. Grangette, C., Gruart, V., Ouaissi, M.A. et al. (1989) IgE receptor on human eosinophils (FcεRII). Comparison with B cell CD23 and association with an adhesion molecule. J Immunol 143, 3580-8.
46. Haak-Frendscho, M., Ridgway, J., Shields, R. et al. (1993) Human IgE receptor alpha-chain IgG chimera blocks passive cutaneous anaphylaxis reaction in vivo. J Immunol 151, 351-8.
47. Hebell, T., Ahearn, J.M. & Fearon, D.T. (1991) Suppression of the immune response by a soluble complement receptor of B lymphocytes. Science 254, 102-5.
48. Hellman, L. (1994) Profound reduction in allergen sensitivity following treatment with a novel allergy vaccine. Eur J Immunol 24, 415-20.
49. Helm, B.A., Marsh, P., Vercelli, D. et al. (1988) The mast cell binding site on human immunoglobulin E. Nature 331, 180-3.
50. Helm, B.A., Ling, Y., Teale, C., Padlan, E.A. & Brüggemann, M. (1991) The nature and importance of the inter-ε chain disulfide bonds in human IgE. Eur J Immunol 21, 1543-8.
51. Henry, A.J., Cook, J.P., McDonnell, J.M. et al. (1997) Participation of the N-terminal region of Cε3 in the binding of human IgE to its high-affinity receptor FcεRI. Biochemistry 36, 15568-78.
52. Hermann, P., Armant, M., Brown, E. et al. (1999) The vitronectin receptor and its associated CD47 molecule mediates proinflammatory cytokine synthesis in human monocytes by interaction with soluble CD23. J Cell Biol 144, 767-75.
53. Hewitt, C.R.A., Brown, A.P., Hart, B.J. & Pritchard, D.I. (1995) A major house dust allergen disrupts the IgE network by selectively cleaving CD23: innate protection by antiproteases. J Exp Med 182, 1537-44.
54. Hibbert, R.G., Teriete, P., Grundy, G.J. et al. (2005) The structure of human CD23 and its interactions with IgE and CD21. J Exp Med 202, 751-60.
55. Holgate, S., Casale, T., Wenzel, S. et al. (2005) The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation. J Allergy Clin Immunol 115, 459-65.
56. Holowka, D., Gosse, J.A., Hammond, A.T. et al. (2005) Lipid segregation and IgE receptor signalling: a decade of progress. Biochim Biophys Acta 1746, 252-9.
57. Holowka, D., Sil, D., Torigoe, C. & Baird, B. (2007) Insights into immunoglobulin E receptor signalling from structurally defined ligands. Immunol Rev 217, 269-79.
58. Hunt, J., Beavil, R.L., Calvert, R.A. et al. (2005) Disulphide linkage controls the affinity and stoichiometry of IgE Fcε3-4 binding to FcεRI. J Biol Chem 280, 16808-14.
59. Inführ, D., Crameri, R., Lamers, R. & Achatz, G. (2005) Molecular and cellular targets of anti-IgE antibodies. Allergy 60, 977-85.
60. Ishizaka, K. & Ishizaka, T. (1967) Identification of γE-antibodies as a carrier of reaginic activity. J Immunol 99, 1187-98.
61. James, L.C., Roversi, P. & Tawfik, D.S. (2003) Antibody multispecificity mediated by conformational diversity. Science 299, 1362-7.
62. Johansson, S.G.O. & Bennich, H. (1967) Immunological studies of an atypical (myeloma) immunoglobulin. Immunology 13, 381-94.
63. Kalesnikoff, J., Huber, M., Lam, V. et al. (2001) Monomeric IgE stimulates signalling pathways in mast cells that lead to cytokine production and cell survival. Immunity 14, 801-11.
64. Karagiannis, S.N., Warrack, J.K., Jennings, K.H. et al. (2001) Endocytosis and recycling of the complex between CD23 and HLA-DR in human B cells. Immunology 103, 319-31.
65. Karagiannis, S.N., Bracher, M.G., Beavil, R.L. et al. (2008) Role of IgE receptors in IgE-dependent cytotoxicity and phagocytosis of ovarian tumor cells by human monocytic cells. Cancer Immunol Immunother, 57, 247-63.
66. Kawakami, T. & Kitaura, J. (2005) Mast cell survival and activation by IgE in the absence of antigen: a consideration of the biologic mechanisms and relevance. J Immunol 175, 4167-73.
67. Kijimoto-Ochiai, S. (2002) CD23 (the low affinity IgE receptor) as a C-type lectin: a multidomain and multifunctional molecule. Cell Mol Life Sci 59, 648-64.
68. Kijimoto-Ochiai, S. & Noguchi, A. (2000) Two peptides from CD23, including the inverse RGD sequence and its related peptide, interact with MHC Class II molecule. Biochem Biophys Res Commun 267, 686-91.
69. Kijimoto-Ochiai, S., Horimoto, E. & Uede, T. (1994) Demonstration of the interaction between the CD23 molecule and the galactose residue of glycoproteins. Immunol Lett 40, 49-53.
70. Kijimoto-Ochiai, S., Noguchi, A., Ohnishi, T. & Araki, Y. (2004) Complex formation of CD23/surface immunoglobulin and CD23/CD81/MHC Class II on an EBV-transformed human B cell line and inferable role of tetraspanin. Microbiol Immunol 48, 417-26.
71. Kilmon, M.A., Ghirlando, R., Strub, M.-P. et al. (2001) Regulation of IgE production requires oligomerization of CD23. J Immunol 167, 3139-45.
72. Kinet, J.-P. (1999) The high-affinity IgE receptor (FcεRI): from physiology to pathology. Annu Rev Immunol 17, 931-72.
73. Kleine Budde, I. & Aalberse, R.C. (2003) Histamine-releasing factors, a heterogeneous group of different activities. Clin Exp Allergy 33, 1175-82.
74. Kraft, S. & Kinet, J.-P. (2007) New developments in FcεRI regulation, function and inhibition. Nat Rev Immunol 7, 365-78.
75. Lecoanet-Henchoz, S., Gauchat, J.-F., Aubry, J.-P. et al. (1995) CD23 regulates monocyte activation through a novel interaction with the adhesion molecules CD11b-CD18 and CD11c-CD18. Immunity 3, 119-25.
76. Lee, W.T., Rao, M. & Conrad, D.H. (1987) The murine lymphocyte receptor for IgE. IV. The mechanism of ligand-specific receptor upregulation on B cells. J Immunol 139, 1191-8.
77. Lemieux, G.A., Blumenkron, F., Yeung, N. et al. (2007) The low affinity IgE receptor (CD23) is cleaved by the metalloproteinase ADAM10. J Biol Chem 282, 14836-44.
78. Liu, F.-T. (1993) S-type mammalian lectins in allergic inflammation. Immunol Today 14, 486-90.
79. Liu, F.-T. (2005) Regulatory roles of galectins in the immune response. Int Arch Allergy Immunol 136, 385-400.
80. Luo, H., Hofstetter, H., Banchereau, J. & Delespesse, G. (1991) Crosslinking of CD23 antigen by its natural ligand (IgE) or by anti-CD23 antibody prevents B lymphocyte proliferation and differentiation. J Immunol 146, 2122-9.
81. McCloskey, N., Hunt, J., Beavil, R.L. et al. (2007) Soluble CD23 monomers inhibit and oligomers stimulate IgE synthesis in human B cells. J Biol Chem 282, 24083-91.
82. McDonnell, J.M., Beavil, A.J., Mackay, G.A. et al. (1996) Structure based design and characterization of peptides that inhibit IgE binding to its high-affinity receptor. Nat Struct Biol 3, 419-26.
83. McDonnell, J.M., Calvert, R., Beavil, R.L. et al. (2001) The structure of the IgE Cε2 domain and its role in stabilizing the complex with its high-affinity receptor FcεRI. Nat Struct Biol 8, 437-41.
84. MacGlashan, D. (2005) IgE and IgE regulation. Ann NY Acad Sci 1050, 73-88.
85. Matsumoto, A.K., Kopicky-Burd, J., Carter, R.H. et al. (1991) Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte containing complement receptor type 2 and CD19. J Exp Med 173, 55-64.
86. Metzger, H. (1992) The receptor with high affinity for IgE. Immunol Rev 125, 37-48.
87. Mongini, P.K., Jackson, A.E., Tolani, S., Fattah, R.J. & Inman, J.K. (2003) Role of complement-binding CD21/CD19/CD81 in enhancing human B cell protection from Fas-mediated apoptosis. J Immunol 171, 5244-54.
88. Naito, K., Hirama, M., Okumura, K. & Ra, C. (1996) Recombinant soluble form of the human high-affinity receptor for IgE prevents anaphylactic shock in mice. J Allergy Clin Immunol 97, 773-80.
89. Nakamura, G.R., Starovasnik, M.A., Reynolds, M.E. & Lowman, H.B. (2001) A novel family of hairpin peptides that inhibit IgE activity by binding to the high-affinity IgE receptor. Biochemistry 40, 9828-35.
90. Oberndorfer, I., Schmid, D., Geisberger, R. et al. (2006) HS1-associated protein X-1 interacts with membrane-bound IgE: impact on receptor-mediated internalisation. J Immunol 177, 1139-45.
91. Ortega, E., Schweitzer-Stenner, R. & Pecht, I. (1991) Kinetics of ligand binding to the type I Fcε receptor on mast cells. Biochemistry 30, 3473-83.
92. Owen, C.E. (2002) Anti-immunoglobulin E therapy for asthma. Pulm Pharmacol Ther 15, 417-24.
93. Padlan, E.A. & Davies, D.R. (1986) A model of the Fc of immunoglobulin E. Mol Immunol 23, 1063-75.
94. Pirron, U., Schlunck, T., Prinz, J.C. & Rieber, E.P. (1990) IgE-dependent antigen focusing by B lymphocytes is mediated by the low-affinity receptor for IgE. Eur J Immunol 20, 1547-51.
95. Plater-Zyberk, C. & Bonnefoy, J-Y. (1995) Marked amelioration of established collagen-induced arthritis by treatment with antibodies to CD23 in vivo. Nat Med 1, 781-5.
96. Pochon, S., Graber, P., Yeager, M. et al. (1992) Demonstration of a second ligand for the low-affinity receptor for immunoglobulin E (CD23) using recombinant CD23 reconstituted into fluorescent liposomes. J Exp Med 176, 389-97.
97. Poggianella, M., Bestagno, M. & Burrone, O.R. (2006) The extracellular membrane-proximal domain of human membrane IgE controls apoptotic signalling of the B cell receptor in the mature B cell line A20. J Immunol 177, 3597-605.
98. Prausnitz, C. & Küstner, H. (1921) Stüdien uber die Ueberempfindlichkeit. Zentralbl Bakteriol Parasit Infektion Hyg 86, 160-9.
99. Presta, L., Shields, R., O'Connell, L. et al. (1994) The binding site on human immunoglobulin E for its high affinity receptor. J Biol Chem 269, 26368-73.
100. Price, N.E., Price, N.C., Kelly, S.M. et al. (2005) The key role of protein flexibility in modulating IgE interactions. J Biol Chem 280, 2324-30.
101. Ravetch, J.V. & Kinet, J.-P. (1991) Fc receptors. Annu Rev Immunol 9, 457-92.
102. Richards, M.L. & Katz, D.H. (1990) The binding of IgE to murine FcεRII is calcium-dependent but not inhibited by carbohydrate. J Immunol 144, 2638-46.
103. Robertson, M.W. & Liu, F.-T. (1991) Heterogeneous IgE glycoforms characterized by differential recognition of an endogenous lectin (IgE-binding protein). J Immunol 147, 3024-30.
104. Rosenwasser, L.J. & Meng, J. (2005) Anti-CD23. Clin Rev Allergy Immunol 29, 61-72.
105. Sarfati, M., Bettler, B., Letellier, M. et al. (1992) Native and recombinant soluble CD23 fragments with IgE suppressive activity. Immunology 76, 662-7.
106. Sayers, I., Cain, S.A., Swan, J.R. et al. (1998) Amino acid residues that influence Fc epsilon RI-mediated effector functions of human immunoglobulin E. Biochemistry 37, 16152-64.
107. Sayers, I., Housden, J.E.M., Spivey, A.C. & Helm, B.A. (2004) The importance of Lys-352 of human immunoglobulin E in FcεRII/CD23 recognition. J Biol Chem 279, 35320-5.
108. Schultz, O., Laing, P., Sewell, H.F. & Shakib, F. (1995) Der p 1, a major allergen of the house dust mite, proteolytically cleaves the lower affinity receptor for human IgE (CD23). Eur J Immunol 25, 3191-4.
109. Schweitzer-Stenner, R. & Pecht, I. (2005) Death of a dogma or enforcing the artificial: monomeric IgE may initiate mast cell response by inducing its receptor aggregation. J Immunol 174, 4461-4.
110. Shakib, F., Schultz, O. & Sewell, H. (1998) A mite subversive: cleavage of CD23 and CD25 by Der p1 enhances allergenicity. Immunol Today 19, 313-16.
111. Sheriff, S., Chang, C.Y. & Ezekowitz, R.A.B. (1994) Human mannose-binding protein carbohydrate recognition domain trimerizes through a triple α-helical coiled-coil. Nat Struct Biol 1, 789-94.
112. Sherr, E., Macy, E., Kimata, H., Gilly, M. & Saxon, A. (1989) Binding the low affinity FcεR on B cells suppresses ongoing human IgE synthesis. J Immunol 142, 481-9.
113. Shi, J., Ghirlando, R., Beavil, R.L. et al. (1997) Interaction of the low-affinity receptor CD23/FcεRII lectin domain with the Fcε3-4 fragment of human immunoglobulin E. Biochemistry 36, 2112-22.
114. Sondermann, P. & Oosthuizen, V. (2002) The structure of Fc/receptor complexes: considerations on stoichiometry and potential inhibitors. Immunol Lett 82, 51-6.
115. Stamos, J., Eigenbrot, C., Makamura, G.R. et al. (2004) Convergent recognition of the IgE binding site in the high-affinity IgE receptor. Structure 12, 1289-301.
116. Stanworth, D.R. (1993) The discovery of IgE. Allergy 48, 67-71.
117. Stanworth, D.R., Jones, V.M., Lewin, I.V. & Nayyar, S. (1990) Allergy treatment with a peptide vaccine. Lancet 336, 1279-81.
118. Sutton, B.J. & Gould, H.J. (1993) The human IgE network. Nature 366, 421-8.
119. Sutton, B.J., Beavil, R.L., Beavil, A.J., Young, R.J. & Gould, H.J. (1997) The structural basis of IgE-receptor interactions in the allergic response. In: Roberts, A.M. & Walker, M.R., eds. Allergic Mechanisms and Immunotherapeutic Strategies. John Wiley & Sons, Chichester, UK, pp. 17-31.
120. Sutton, B.J., Beavil, R.L. & Beavil, A.J. (2000) Inhibition of IgE-receptor interactions. Br Med Bull 56, 1004-18.
121. Szakonyi, G., Guthridge, J.M., Li, D. et al. (2001) Structure of complement receptor 2 in complex with its C3d ligand. Science 292, 1725-8.
122. Vangelista, L., Cesco-Gaspere, M., Lorenzi, R. et al. (2002) A minimal receptor-Ig chimera of human Fc epsilon RI alpha-chain efficiently binds secretory and membrane IgE. Protein Eng 15, 51-7.
123. Vangelista, L., Soprana, E., Cesco-Gaspere, M. et al. (2005) Membrane IgE binds and activates FcεRI in an antigen-independent manner. J Immunol 174, 5602-11.
124. Vercelli, D., Helm, B.A., Marsh, P. et al. (1989) The B-cell binding site on human immunoglobulin E. Nature 338, 649-51.
125. Wan, T., Beavil, R.L., Fabiane, S.M. et al. (2002) The crystal structure of IgE Fc reveals an asymmetrically bent conformation. Nat Immunol 3, 681-6.
126. Wang B., Rieger, A., Kilgus, O. et al. (1992) Epidermal Langerhans cells from normal human skin bind monomeric IgE via FcεRI. J Exp Med 175, 1353-8.
127. Wang, C.Y., Walfield, A.M., Fang, X. et al. (2003) Synthetic IgE peptide vaccine for immunotherapy of allergy. Vaccine 21, 1580-90.
128. Weis, W.I. & Drickamer, K. (1994) Trimeric structure of a C-type mannose-binding protein. Structure 2, 1227-40.
129. Weis, W.I., Drickamer, K. & Hendrickson, W.A. (1992) Structure of a C-type mannose-binding protein complexed with an oligosaccharide. Nature 360, 127-34.
130. Weskamp, G., Ford, J.W., Sturgill, J. et al. (2006) ADAM 10 is a principal "sheddase" of the low-affinity immunoglobulin E receptor CD23. Nat Immunol 7, 1293-8.
131. Williams, A.F. & Barclay, A.N. (1988) The immunoglobulin superfamily: domains for cell surface recognition. Annu Rev Immunol 6, 381-405.
132. Wurzburg, B.A., Garman, S.C. & Jardetzky, T.S. (2000) Structure of the human Cε3-Cε4 reveals conformational flexibility in the antibody effector domains. Immunity 13, 375-85.
133. Wurzburg, B.A., Tarchevskaya S.S. & Jardetzky, T.S. (2006) Structural changes in the lectin domain of CD23, the low-affinity IgE receptor, upon calcium binding. Structure 14, 1049-58.
134. Yokota, A., Yukawa, K., Yamamoto, A. et al. (1992) Two forms of the low-affinity Fc receptor for IgE differentially mediate endocytosis and phagocytosis: identification of the critical cytoplasmic domains. Proc Natl Acad Sci USA 89, 5030-4.
135. Young, R.J., Owens, R.J., Mackay, G.A. et al. (1995) Secretion of recombinant human IgE-Fc by mammalian cells and biological activity of glycosylation site mutants. Protein Eng 8, 193-9.
136. Yu, P., Kosco-Vilbois, M., Richards, M., Köhler, G. & Lamers, M.C. (1994) Negative feedback regulation of IgE synthesis by murine CD23. Nature 369, 753-6.
137. Zheng, Y., Shopes, B., Holowka, D. & Baird, B. (1991) Conformations of IgE bound to its receptor FcεRI and in solution. Biochemistry 30, 9125-32.
138. Zheng, Y., Shopes, B., Holowka, D. & Baird, B. (1992) Dynamic conformations compared for IgE and IgG1 in solution and bound to receptors. Biochemistry 31, 7446-56.
139. Zuberi, R.I., Frigeri, L.G. & Liu, F-T. (1994) Activation of rat basophilic leukaemia cells by εBP, an IgE-binding endogenous lectin. Cell Immunol 156, 1-12.
140. Zuberi, R.I., Hsu, D.K., Kalayci, O. et al. (2004) Critical role for galectin-3 in airway inflammation and bronchial hyper-responsiveness in a murine model of asthma. Am J Pathol 165, 2045-53.